Trials / Terminated
TerminatedNCT03935126
Global Atrophie Biomarker Evaluation Study (GABiE)
A Biomarker Evaluation Study in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration (AMD) Evaluating the Use of Microperimetry (Fundus-controlled Perimetry) and Swept Source-OCT in Assessing Changes in Retinal Sensitivity and Anatomy Over Time.
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 3 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the use of microperimetry and SS-OCT in assessing the natural changes of retinal sensitivity and anatomy in the perilesional zone of geographic atrophy areas in patients with dry age-related macular degeneration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Diagnostics | Diagnostics |
Timeline
- Start date
- 2019-05-07
- Primary completion
- 2020-05-06
- Completion
- 2020-05-14
- First posted
- 2019-05-02
- Last updated
- 2021-05-21
- Results posted
- 2021-05-21
Locations
2 sites across 2 countries: United States, Switzerland
Source: ClinicalTrials.gov record NCT03935126. Inclusion in this directory is not an endorsement.